As of December 2024, the company held about $1.2 billion of cash and ... Since purchasing Solexa with its Genome Reader instrument in 2007, Illumina’s continued innovation significantly reduced ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor ...

Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its ...

China’s Ministry of Commerce announcement does not mention Illumina’s reagents used in DNA sequencing ... to avoid paying tariffs until April 2 on goods that fall under the United States ...

Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country. Previously ...

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...

But now, Illumina has closed that loop. Just a few days before the biggest genomics conference of the year, Advances in Genome Biology ... there will likely be a 2–4x reduction in price in ...

"Illumina has set the standard in whole genome sequencing, and now, with Broad's deep experience and long history of translating complex molecular biology assays into high-throughput, high quality ...

Scientists have also generated more than 17 million SARS-CoV-2 genome sequences so far, more than for any other organism. This has given an unparalleled view into the ways in which the virus ...